Skip to Content
Upcoming Webinar

Educational & Equity Implications of Biomarker Testing & Targeted Therapy Access in NSCLC

Date: February 17, 2026 | 2:00 PM

Date: Tuesday, February 17 | 2 p.m. EST
Presenter: Shawnny Eugene, PharmD, MBA, MS | NCODA

Differences in education, resources, and access can influence whether biomarker testing leads to timely targeted therapy in NSCLC.

In this CE-accredited session, Shawnny Eugene will discuss the equity considerations tied to biomarker testing and treatment access.

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.